Guidelines
Key Populations
UNAIDS Series: Engaging uniformed services in the fight against AIDS - Case Study 1
Fighting AIDS
USAID Office of HIV/AIDS
March 8-9, 2016
HIV testing services
Policy Brief
November 2018
WHO/CDS/HIV/18.48
Original Research
Rev Panam Salud Publica 43, 2019 | www.paho.org/journal | https://doi.org/10.26633/RPSP.2019.31
Yaya et al. BMC Pregnancy and Childbirth (2018) 18:194
Ensuring equitable access to maternal health care including antenatal, delivery, postnatal services
and fertility control methods, is one of the most critical challenges for public health sector. There are significant
disparities in materna...l health care indicators across many geographical locations, maternal, economic, sociodemographic
factors in many countries in sub-Sahara Africa. In this study, we comparatively explored the utilization
level of maternal health care, and examined disparities in the determinants of major maternal health outcomes
more
The report shows that where people and communities living with and affected by HIV are engaged in decision-making and HIV service delivery, new infections decline and more people living with HIV gain access to treatment. When people have the power to choose, to know, to thrive, to demand and to work... together, lives are saved, injustices are prevented and dignity is restored.
more
BMC Public Health (2016) 16:766
DOI 10.1186/s12889-016-3455-5
Plan d’actions de la Politique du Secteur Santé pour la Nutrition 2016-2020 - Plan Exhaustif
Le renforcement des actions de promotion de l’allaitement maternel notamment la mise au sein précoce et l’allaitement maternel exclusif pendant les six premiers mois de vie, constitue est une priorité absolue dans la stratégie de réduction de la mortalité infantile au Bénin. En effet, le l...ait maternel est l’aliment idéal pour les nouveau-nés et les nourrissons. L’allaitement maternel est un puissant rempart contre la diarrhée, les infections respiratoires aiguës et la malnutrition.
more
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...t
regimen [1]. The number of these patients is not negligible.
In 2014, of the 6.3 million TB cases that were notified
by National TB Programmes (NTPs) to the World Health
Organization (WHO), approximately 700,000 patients were
already previously treated
more
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for... the first two to five products to become available in about 10 years.
more
Research Article
Hindawi
BioMed Research International
Volume 2018, Article ID 9619684, 10 pages https://doi.org/10.1155/2018/9619684